Literature DB >> 24471773

Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls.

H Jiang1, Y M Sun, Y Hao, Y P Yan, K Chen, S H Xin, Y P Tang, X H Li, T Jun, Y Y Chen, Z J Liu, C R Wang, H Li, Z Pei, H F Shang, B R Zhang, W H Gu, Z Y Wu, B S Tang, J-M Burgunder.   

Abstract

BACKGROUND AND
PURPOSE: Huntington's disease is due to a CAG triplet repeat elongation in the huntingtin gene. Boundaries in CAG numbers have been found between healthy people with and without risk to pass the disorder to the next generation, and between people without, with a mild, or with a fully penetrant phenotype. These data have been generated in western populations and it is not clear whether they are also valid amongst Chinese.
METHODS: In order to establish normative data in the huntingtin gene for Chinese people, 966 chromosomes from normal controls were tested. Further, the range of CAG repeats was examined in a cohort from six centres and a total of 368 patients with the disease were included.
RESULTS: The CAG triplet repeat range in normal controls was between 9 and 35 (mean 18.9, SD 2.57). Triplets in the range between 26 and 35 were found in 2.5%. In the patient cohort, triplet repeats in the shorter allele were between 8 and 37 (mean 17.7, SD 1.6). In the longer allele, a range between 36 and 120 was found. There was a negative correlation (-0.65, r = 0.42) between age at onset and the number of triplet repeats in the larger allele. The mean age at onset was 38 years, with a range between 2 and 70 years. In 23 patients (6%) a childhood or juvenile onset was noted.
CONCLUSION: These data show comparable ranges of huntingtin gene CAG triplet repeats in normal people and in patients with Huntington's disease as in western populations.
© 2014 The Author(s) European Journal of Neurology © 2014 EFNS.

Entities:  

Keywords:  CAG repeats; China; Huntington's disease; huntingtin gene; normative data

Mesh:

Substances:

Year:  2014        PMID: 24471773     DOI: 10.1111/ene.12366

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

Review 1.  Development of Research on Huntington Disease in China.

Authors:  Hong-Lei Li; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

Review 2.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 3.  Huntington Disease in Asia.

Authors:  Miao Xu; Zhi-Ying Wu
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

4.  Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Authors:  Hong-Lei Li; Xiao-Yan Li; Yi Dong; Yan-Bin Zhang; Hong-Rong Cheng; Shi-Rui Gan; Zhi-Jun Liu; Wang Ni; Jean-Marc Burgunder; X William Yang; Zhi-Ying Wu
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

Review 5.  Allele-specific genome targeting in the development of precision medicine.

Authors:  Junjiao Wu; Beisha Tang; Yu Tang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

6.  Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches.

Authors:  Wen-Juan Huang; Wei-Wei Chen; Xia Zhang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

7.  Targeting N-Terminal Huntingtin with a Dual-sgRNA Strategy by CRISPR/Cas9.

Authors:  Junjiao Wu; Yu Tang; Chun-Li Zhang
Journal:  Biomed Res Int       Date:  2019-11-16       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.